In order to address relevant issues related to the Ayurvedic pharmacopoeia, the APA has an active Ayurvedic Pharmacopoeia Committee, which is run by APA members as well as other experts and advisers within the field.
It is the responsibility of the Ayurvedic Pharmacopoeia Committee to ensure that APA members are aware of current legislative, safety and conservation issues associated with the use of traditional Ayurvedic remedies in the UK. This awareness is essential for practitioners in order to practise Ayurveda in a way that is safe, sustainable and protective of the health of the public. In particular, members of the APA register are required to:
- take personal responsibility for practising Ayurveda in accordance with UK law in a safe fashion and professional manner
- be aware of
- known contraindications for using Ayurvedic remedies
- traditional contraindications
- herb-herb and drug-herb interactions
- any toxicity issues concerning remedies from the Ayurvedic pharmacopoeia and understand appropriate dosage, purification and prescription methods.
- understand that conservation of endangered species, the use of sustainably harvested herbs and the promotion of the health of the environment are of central importance to fulfilling the duties of an Ayurvedic practitioner.
- report any adverse reactions and inappropriate remedy usage via the Yellow Card Reporting Scheme.
The Ayurvedic Pharmacopoeia Committee will therefore:
- keep members of the APA informed of all current legislative and conservation issues related to the safe, legal and sustainable use of Ayurvedic remedies.
- aspire to protect the Ayurvedic pharmacopoeia from misrepresentation and unsustainable use.
- promote research into the safe and effective use of Ayurvedic remedies.
- communicate with relevant government bodies regarding any legislation that affects the use of Ayurvedic remedies in the UK.
- collate accurate scientific documentation on the safety of Ayurvedic remedies in order to protect the Ayurvedic pharmacopoeia and to uphold the access to safe and effective remedies for practitioners.
- be responsible for managing a Yellow Card Adverse Event Reporting Scheme for members to report any adverse reactions.
To contact the APA Pharmacopoeia Committee, please email info@apa.uk.com


